Taking at least one aspirin every week is linked to the development of age-related vision loss, according to an Australian study that looked at information collected over 15 years.
Delegations from some 140 countries agreed Saturday to adopt a ground-breaking treaty limiting the use and emission of health-hazardous mercury, the U.N. said, although environmental activists lamented it did not go far enough.
The Department of Health (DOH)'s restrictions on medicines containing ephedrine have caused a shortage of rhinitis medicines, a DOH official said yesterday.
Over fifty veterinarians are appealing for amendments to legalize the use of human medicine on animals, stating that they cannot conduct treatments under current conditions, a local newspaper reported yesterday.
A cooperative project between Taiwan and the United States in the field of medical technology has proved successful and can now be used as a stepping stone for Taiwan to seek more business in that area, Taiwan's National Applied Research Laboratories (NARL) said.
Over 20,000 elderly people above the age of 65 spend NT$280,000 on medicine annually, according to statistics from the health bureau.
Ketamine could be upgraded to a Class 2 drug from its current Class 3 designation at a narcotics evaluation committee meeting to be held Thursday, the Ministry of Justice (MOJ) announced yesterday.
Academia Sinica, Taiwan's top research institute, and a Switzerland-based pharmaceutical company signed a memorandum of understanding (MOU) yesterday aimed at furthering exchanges in translational medicine.
The Ministry of Justice (MOJ) announced yesterday that it will invite officials from the Department of Health, the Ministry of Education and other governmental organs to take part in a meeting on Dec. 27 with its narcotics evaluation committee to decide whether or not to upgrade ketamine (K他命) to a Class 2 drug.